The effects of anti-PD-1 therapy on programmed death-ligand 1 expression and glucose metabolism of normal organs in patients with advanced non-small cell lung cancer. - Severyn M; Lee EHL; Chand G; Johnson J; Bailey D; Adamson K; Goh V; Hughes DJ; Cook GJR (BJR open, 2025)